|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Restricted cash | |||||||||||||
| Investments | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Inventories | |||||||||||||
| Prepayments and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Non-current assets | |||||||||||||
| Operating lease right-of-use assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Intangible assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Deferred tax assets | |||||||||||||
| Other non-current assets | |||||||||||||
| Total non-current assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||
| Current liabilities | |||||||||||||
| Current portion of long-term borrowings | |||||||||||||
| Accounts payable | |||||||||||||
| Contract liabilities | |||||||||||||
| Current operating lease liabilities | |||||||||||||
| Income tax payable | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Contingent consideration | |||||||||||||
| Total current liabilities | |||||||||||||
| Non-current liabilities | |||||||||||||
| Long-term borrowings | |||||||||||||
| Operating lease liabilities, non-current | |||||||||||||
| Deferred tax liabilities | |||||||||||||
| Finance lease obligations, non-current | |||||||||||||
| Non-current income tax payable | |||||||||||||
| Contingent consideration | |||||||||||||
| Total non-current liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Commitments and contingencies | |||||||||||||
| Shareholders’ equity | |||||||||||||
| Treasury shares, at cost (237,269 and 609,390 shares held as of December 31, 2025 and 2024, respectively) | |||||||||||||
| Subscription receivable from ordinary shares | |||||||||||||
| Treasury shares, at cost (491,831 and 237,269 shares held as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||
| Common stock issued | |||||||||||||
| Class A ordinary shares | |||||||||||||
| Class B ordinary shares | |||||||||||||
| Common stock, par value (in USD per share) | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated other comprehensive income | |||||||||||||
| Retained earnings | |||||||||||||
| Total shareholders’ equity | |||||||||||||
| Total liabilities and shareholders’ equity | |||||||||||||
| Common stock, shares outstanding (in shares) | |||||||||||||
| Class A ordinary shares | |||||||||||||
| Class B ordinary shares | |||||||||||||
| Total common stock, shares outstanding (in shares) |
Loading...